Last week my quest for blogging stardom got a big boost -- the Wall Street Journal cited Pharma Marketing Blog as a blog insiders should read to stay current!
Consumer Detailing by Medsite is a novel rich-media online consumer disease education and drug information program.
Johnson & Johnson is unveiling a new approach to TV and print campaigns that deals head-on with safety, putting drug risks on more-equal footing with drug benefits. This article summarizes the results of a survey about whether or not the rest of the pharma industry should follow J&J's lead.
Now there is a method proven to predict the success of a campaign prior to launch. The ProSigma Detail Model created by TargetRx, a marketing information services company located in Horsham, PA, helps pharmaceutical marketers develop the best detail and detail piece to drive prescribing behavior.
Nearly 70 people showed up at the Second Annual Networking Dinner Reception on May 18, 2005, in Metuchen, New Jersey. Attendees spent several hours networking, enjoying dinner, and brain-storming ideas about how to improve the Network and the services offered.
All marketers are bullshitters! What are some noteworthy examples of pharmaceutical marketing bullshit? How does marketing bullshit hurt the industry?
This article reviews Lathian Systems' online solutions that are designed to help pharma companies capture the interest, gain the access, and obtain the time required to deliver effective educational programs to physicians.
Several recent surveys indicate that pharmaceutical companies will spend more money on e-mail marketing to consumers in 2005. Perhaps they should also spend some money and time to ensure that their email campaigns adhere to emerging best practices with regard to privacy, HIPAA, SPAM, and permission-based marketing.
A panel of experts at a recent continuing medical education conference discussed issues relating to the compliance with the 2004 Updated ACCME Standards for Commercial Support: Standards to Ensure the Independence of CME.
Does the FDA Need to be Overhauled? By John Mack (Bio) SUMMARY The Vioxx withdrawal put the Food and Drug Administration (FDA) under...